SCHEMBL23218690

SCHEMBL23218690

COc1ccc(CC(=O)O)c(OCc2nn(C)c3ccc(-c4ccnc(CN)c4)cc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 2/20 0.37
CSF1R P07333 3/20 0.36
PDGFRB P09619 3/20 0.36
HSD17B10 Q99714 1/20 0.35
NAMPT P43490 1/20 0.34
P2RX3 P56373 1/20 0.34
PLG P00747 1/20 0.34
PLAU P00749 1/20 0.34
F11 P03951 1/20 0.34
KLKB1 P03952 1/20 0.34
F7 P08709 1/20 0.34
TPSB2 P20231 1/20 0.34
MET P08581 2/20 0.34
PDGFRA P16234 1/20 0.34
KDR P35968 1/20 0.34
AKR1C3 P42330 2/20 0.33
PTGS1 P23219 2/20 0.33
NR3C2 P08235 1/20 0.33
CYSLTR2 Q9NS75 1/20 0.33
CYSLTR1 Q9Y271 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29592684 1.00 CFD (0.37) CFDCSF1RPDGFRBHSD17B10NAMPT
SCHEMBL23218704 0.90 CFD (0.39) CFDCSF1RPDGFRBHSD17B10NAMPT
SCHEMBL29591491 0.87 CFD (0.50) CFDP2RX3PLGPLAUF11
SCHEMBL23218852 0.87 CFD (0.50) CFDP2RX3PLGPLAUF11
SCHEMBL29122145 0.86 PLAU (0.36) CSF1RPDGFRBHSD17B10NAMPTP2RX3
SCHEMBL23218815 0.85 AKR1C3 (0.37) CFDCSF1RPDGFRBHSD17B10NAMPT
SCHEMBL29593254 0.85 AKR1C3 (0.37) CFDCSF1RPDGFRBHSD17B10NAMPT
SCHEMBL23218951 0.83 CFD (0.43) CFDP2RX3PLGPLAUF11
SCHEMBL29591865 0.83 CFD (0.43) CFDP2RX3PLGPLAUF11
SCHEMBL29121568 0.82 P2RX3 (0.37) CFDCSF1RPDGFRBNAMPTP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed